.-Hypoxia causes a regulated decrease in body temperature (T b ), and nitric oxide (NO) is now known to participate in hypoxia-induced hypothermia. Hypoxia also inhibits lipopolysaccharide (LPS)-induced fever. We tested the hypothesis that NO may participate in the hypoxia inhibition of fever. The rectal temperature of awake, unrestrained rats was measured before and after injection of LPS, with or without concomitant exposure to hypoxia, in an experimental group treated with N -nitro-Larginine (L-NNA) for 4 consecutive days before the experiment and in a saline-treated group (control). L-NNA is a nonspecific NO synthase inhibitor that blocks NO production. LPS caused a dose-dependent typical biphasic rise in T b that was completely prevented by hypoxia (7% inspired oxygen). L-NNA caused a significant drop in T b during days 2-4 of treatment. When LPS was injected into L-NNA-treated rats, inhibition of fever was observed. Moreover, the effect of hypoxia during fever was significantly reduced. The data indicate that the NO pathway plays a role in hypoxia inhibition of fever.endothelium-derived relaxing factor; temperature; nitric oxide synthase; lipopolysaccharide FEVER IS A REGULATED INCREASE in body temperature (T b ) often described as a rise in the thermoregulatory set point. The rise in T b caused by fever is the actively inducting heat-gain effectors, such as an increase in metabolic heat production (shivering and nonshivering thermogenesis) and a decrease in heat loss and heatseeking behavior (3). It is generally accepted that products of the immune system (cytokines) mediate fever (19) and that animals injected with lipopolysaccharide (LPS) produce several cytokines.A revolution in the understanding of blood pressure control started after the description of the endotheliumderived relaxing factor (14), which was later identified as nitric oxide (NO) (24). Recently, it has been reported that NO also plays an important role in thermoregulation. It has been shown that NO is required for the production of fever (27) and that the L-arginine-NO pathway in the central nervous system (CNS) is necessary to produce hypoxia-induced hypothermia (4). The family of NO synthases (NOS), the enzymes that produce NO in vivo, consists of two different classes, i.e., the inducible and constitutive forms (5) that can be blocked by arginine analogs such as N -nitro-L-arginine (L-NNA) (21).Most animals respond to a shortage of oxygen by lowering their T b . This response should be adaptive because it decreases O 2 demand when availability of oxygen is limited (22), promotes a leftward shift of the oxyhemoglobin dissociation curve, and blunts the energetically costly response to hypoxia, e.g., increased cardiac output and ventilation (32). Moreover, hypoxia leads to activation of the NO-guanosine 3Ј,5Ј-cyclic monophosphate pathway in the CNS (4), and central NO is known to cause a reduction in T b (4,8).Previous studies have established that, during fever produced by endotoxin injection, the increase in T b is markedly reduced by...